HEI's Alfonso Iorio leads team developing approach to assess hemophilia research

May 25, 2018, 10:29 AM by Joel Tiller
Patients are helping researchers, including those at McMaster University, clarify the essential aspects of assessing the value of gene therapy in hemophilia.

Patients are helping researchers, including those at McMaster University, clarify the essential aspects of assessing the value of gene therapy in hemophilia. 

The patients were part of the coreHEM initiative, which this week announced the publication of a core set of outcomes sought for clinical trials of gene therapy in hemophilia. 

Patients have a central role, said Alfonso Iorio, professor of McMaster Department of Health Research Methods, Evidence and Impact and a co-principal investigator of the project.

Read more.